Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis
Protocol ID
LCH-IV
Disease (Sub Disease)
Langerhans Cell Histiocytosis
Diagnosis Stage
New diagnosis
Location
NSW, QLD, VIC, WA, NZ, TAS
Sponsor
North American Consortium for Histiocytosis
Collaborators
Histiocyte Society
Links
Trial Status
Open
Sites
The Children's Hospital at Westmead
John Hunter Children's Hospital
Monash Children's Hospital
Perth Children's Hospital
Queensland Children's Hospital
Sydney Children's Hospital
Royal Children's Hospital
Royal Hobart Hospital
Christchurch Hospital
Starship Hospital
John Hunter Children's Hospital
Monash Children's Hospital
Perth Children's Hospital
Queensland Children's Hospital
Sydney Children's Hospital
Royal Children's Hospital
Royal Hobart Hospital
Christchurch Hospital
Starship Hospital
Study Type
Treatment
Phase
Phase 3
Age Eligibility
up to 18 years
International registry ID's
NCT02205762
| Study Title | International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis |
|---|---|
| Protocol ID | LCH-IV |
| Disease (Sub Disease) | Langerhans Cell Histiocytosis |
| Diagnosis Stage | New diagnosis |
| Location | NSW / QLD / VIC / WA / NZ / TAS |
| Sponsor | North American Consortium for Histiocytosis |
| Collaborators | Histiocyte Society |
| Links | https://clinicaltrials.gov/ct2/show/NCT02205762 |
| Trial Status | Open |
| Trial Open Date | 14/04/2014 |
| Sites | The Children's Hospital at Westmead / John Hunter Children's Hospital / Monash Children's Hospital / Perth Children's Hospital / Queensland Children's Hospital / Sydney Children's Hospital / Royal Children's Hospital / Royal Hobart Hospital/ Christchurch Hospital / Starship Hospital |
| Study Type | Treatment |
| Phase | Phase 3 |
| Age Eligibility | up to 18 years |
| International registry ID's | NCT02205762 |